Eosinophilic Esophagitis Steroid Safety Study

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Eosinophilic Esophagitis
Trial Locations (4)

49202

Institute of Gastroenterology, Nutrition and Liver Diseases; Schneider Children's Medical Center of Israel, Petah Tikva

115 27

"Athens Children's Hospital AGIA SOPHIA", Athens

Unknown

"Department of Woman, Child and General and Specialized Surgery, University of the Campania Luigi Vanvitelli", Naples

Maternal and Child Health Department, Sapienza, Rome

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT04416217 - Eosinophilic Esophagitis Steroid Safety Study | Biotech Hunter | Biotech Hunter